IHT Wealth Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-38
Closed -$1K 1629
2018
Q1
$1K Hold
38
﹤0.01% 1675
2017
Q4
$1K Hold
38
﹤0.01% 1680
2017
Q3
$1K Hold
38
﹤0.01% 1416
2017
Q2
$12 Hold
38
0.01% 935
2017
Q1
$0 Hold
38
﹤0.01% 1349
2016
Q4
$1K Buy
+38
New +$650 ﹤0.01% 1192

IHT Wealth Management's IPXL Position: Q2 2018 in Review

IHT Wealth Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 38 shares — an estimated $1K sold.

IHT Wealth Management first reported a position in IPXL in Q4 2016 and held it in 6 quarters. The position peaked at $1K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • IHT Wealth Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • IHT Wealth Management sold 38 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1K.
  • IHT Wealth Management first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 6 quarters.
  • IHT Wealth Management's Impax Laboratories, Inc. position peaked at $1K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.